Loading...

ASH ASHLAND INC Disposals and divestitures 8-K Filing

SHLN

SH

ASHLAND INC

(ASH)

2024 8-K

Quarterly Results

CEO Equity Grant

Annual Meeting Results

Earnings Announcement

Director Resignation

Financial Statements

Financial Statements

Management Changes

Management Departure

Earnings Announcement

Director Departure

Receivables Agreement Update

Results of Operations and F...

Appointment of Director

Material Impairments

Earnings Reports

Appointment of Director

Departure of Directors or C...

Results of Operations and F...

Annual Meeting Results

Equity Award Grant to CEO

Appointment of Director

Results of Operations and F...

Results of Operations and F...

Entry into a Material Agree...

Amendment to Form 8-K

Earnings Releases

Management Changes

Dividend Increase and Share...

Results of Operations and F...

Agreement Amendments

Results of Operations and F...

Annual Meeting Results

External Links:

Ashland Inc. has entered into a definitive agreement to sell its nutraceuticals business, resulting in a non-cash impairment charge of $110 million to $120 million in the third quarter of fiscal 2024.

AI Assistant

ASHLAND INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.